Baseline characteristics of 26 febrile neutropenic patients

Laboratory characteristics

Patients were evaluated regarding the complete blood count, renal function test, and hepatic function tests. All our patients were febrile neutropenia; 90% of our patients were anemic (<8 xss=removed>9/L (range 0.2–1.45 × 109/L. The median platelet count was 30 × 109/L (20–50 × 109/L) and 27% of all patients presented with bleeding at the presentation from any site. As acute kidney injury (AKI) is the most common complication of sepsis, 10% of our patients identified as AKI and three of our patients required hemodialysis. As the acute leukemic patients generally nutritionally debilitated, the median albumin level of our patients was 2.9 g/dL. Hepatic dysfunction due to sepsis or leukemia or drug-induced presented in 10% patients.

Imaging evaluation

HRCT was carried out on the patients with febrile neutropenia with pulmonary infection. The objective findings were lobar/lobular consolidation (50%), nodule (27%), ground glass opacity (23%), and effusion (11.5%) All the radiologic images were reviewed by independent radiologists. After radiologic review, 39% were classified as bacteria and 31% of the population classified as a fungal infection. Thirteen per cent of the patients were classified as mixed infection as per radiology.

Bronchoalveolar lavage quality assessment

BAL quality assessment was done using physical as well as microbiological techniques. Chamberlin's criteria were used for quality assessment. Inadequate BAL sample was found in 5% of all samples collected. The complications of BAL are as follows: The procedure of bronchoscopy was well tolerated by the patients and the problems encountered (tachycardia – 11, hypoxia – 4, and throat pain – 8) were mild and reversible. One patient developed episodes of epistaxis postbronchoscopy, which was managed with conservative treatments.

Serum and bronchoalveolar lavage galactomannan

Galactomannan was analyzed using enzyme-linked immunosorbent assay and 46% of our patients diagnosed as EORTC-MSG probable/possible invasive aspergillosis group. Serum galactomannan test came positive (optical density (OD) > 0.5) in 8/26 (30.7%) and BAL galactomannan positive (OD >1) in 4/26 (15.3%). A total of 17 microbiological isolates identified by BAL bacterial culture and 8 organisms isolated by blood culture. BAL fungal stain and culture identified two Aspergillus flavus species and one Aspergillus terreus species. We also stained and cultured the entire specimen for TB GeneXpert and Ziehl–Neelsen stain and Lowenstein–Jensen media culture but none of them. We did stain for Norcardia and Actinomycosis and anaerobic culture as a case-to-case basis. Cytomegalovirus polymerase chain reaction (PCR) was done for two patients. PCR for Pneumocystis carinii came positive for one patient [Table 2]. We correlate between the radiologic findings with the microbiological determination. Patients with fungal pneumonia the diagnostic etiology by radiology review a positive correlation exists with serum or BAL galactomannan elevation (r = +0.46) and with documented fungal isolation (r = +0.37). Patients were followed up up to 30-day postadmission. More than half of our patients recovered with antibiotic and inotrope support and 41% of our patients died. For majority of cases, the cause of death was due to multiorgan failure. The most common diagnosis at death was the refractory shock (80%), respiratory failure (15%), and pulmonary hemorrhage (5%).

Species distribution of microbiologically documented patients

Discussion

Chemotherapy for hematological malignancies cause profound suppression of immune system and adversely affects the gastrointestinal mucosal integrity, and hence, they are at a heightened risk for invasive infection due to colonizing bacteria or fungi that translocate across intestinal mucosal surfaces. Profound prolonged neutropenia is most likely to occur in the preengraftment phase of allogeneic hematopoietic cell transplantation, and patients undergoing induction chemotherapy for acute leukemia are at risk of serious infection as compared to another chemotherapy schedule.

Pulmonary infection is the most common site of infection in patients with hematologic malignancies with febrile neutropenia.[2],[6] We carried out the present study to evaluate the pulmonary infection in neutropenic patients using BAL and compare with the conventional method of diagnosis, e.g., clinical, radiology, blood, and BAL culture. The uniqueness of study population as it included the selected group of febrile neutropenic patients with hematologic malignancy. Fever in neutropenic patients is an emergency as it is almost always indicative of an underlying infective etiology. However, localizing signs may be subtle or absent. Respiratory signs were present in three-quarter of the patients in the present study, indicating that signs and symptoms of respiratory infection are blunted in many of these patients, as they are immunosuppressed. In contrast to the global trends of Gram-positive bacteria as the predominant infecting agent in febrile neutropenic patients, most of our isolated were Gram-negative organism 13/17 (76%). Gram-positive bacteria were not isolated separately in our study. This may be partly due to the fact that effective antibiotics active against Gram-positive bacteria were incorporated early as part of empirical antibiotic therapy and the pattern of infection has a significant geographic variation. Among the Gram-negative pathogens isolates, in 4/13 patients, extended-spectrum beta-lactamases positive bacteria were isolated. This points out to the emergence of these types of organisms as an important cause of infection in these patients. This also highlights the importance of using antibiotics that are capable of neutralizing the β-lactamase, produced by these organisms and incorporating them into upfront empirical antibiotic combinations. Therefore, each institution must have an antibiotic policy based on local prevalence and sensitivity patterns. In this aspect, BAL forms an important diagnostic tool for these patients to optimize antimicrobial treatment. In 2 out of 17 patients in whom organism was isolated, multiple bacteria or fungus were grown simultaneously. This may represent actual infection with more than one bacterium or may be due to contaminants. One of the disadvantages of the fiber optic bronchoscopy (FOB) is the possible contamination during its introduction through the nasal passage. Therefore, it is important to be careful during the procedure of collection and transport of the BAL specimen. Surveillance cultures from the upper airways and correlation with the BAL isolates may be helpful in distinguishing between contamination from the upper airway and true infection of the lower respiratory tract. Quantitative estimation of the cultures also would be helpful in this regard.

Invasive mycoses are one of the major causes of mortality in patients with febrile neutropenia. Patients undergoing treatment for hematologic malignancies have an estimated cause-specific mortality due to invasive fungal infections (IFI) of 35%.[3],[7],[8] In an EORTC/MSG study, factors significantly associated with the development of IFI/invasive mold infection are prolonged neutropenia, prolonged use of systemic corticosteroid, T-cell suppressive therapy, and recent SCT (<6 href="https://www.thieme-connect.com/products/ejournals/html/10.4103/ijmpo.ijmpo_39_18#JR_9" xss=removed>9] Similarly, relative or absolute T-cell deficiency or suppression by drugs is the major risk factor for the development of symptomatic pneumocystis infection.[10] Fungi could be grown in culture from three patients. However, none of the patients stained positive for fungi from the direct KOH examination indicates the relative insensitivity of KOH preparation. Twenty-two patients have received amphotericin-B as part of empirical treatment before bronchoscopy, which might have been a reason for KOH preparation being negative. The sensitivity of the organism to antifungals drugs was not done in our study. Strong clinical or radiological evidence of fungal infection should be treated with the full course of antifungal therapy, as BAL cultures can be sterile for fungi, especially if the patient has already been started on antifungal therapy empirically. In our study, one patient came positive for P. carinii. The radiology was corroborative of these findings. She recovered from the Pneumocystis pneumonia after starting of trimethoprim-based therapy.

In neutropenic patients, only about 10% of conventional chest radiographs show abnormalities, whereas CT in these patients reveals pathological findings in 50% of cases.[11] For evaluation of pneumonia, HRCT with subsequent guided BAL has been recommended as the most sensitive technique.[12] HRCT is the preferred sequence of choice due to its thin collimation, more sensitive in detecting small nodule <5 href="https://www.thieme-connect.com/products/ejournals/html/10.4103/ijmpo.ijmpo_39_18#JR_13" xss=removed>13] We correlate between the radiologic findings with the microbiological determination. In patients with fungal pneumonia, the diagnostic etiology by radiologic review, a positive correlation exists with serum or BAL galactomannan elevation (r = +0.46) and with documented fungal isolation (r = +0.37). The possible reasons for the lower strength of correlation were due to the low yield of fungal culture and low sample size.

The median duration of days between onset of symptoms and bronchoscopic evaluation was 9.8 days. This delay was due to the fact that most of our patients who developed pneumonitis had a hemodynamically unstable and poor performance status for withstanding the bronchoscopy procedure. Furthermore, we had to ensure a platelet count of at least 50,000/mm3 before bronchoscopy. Most of our patients (90%) received single donor platelet before bronchoscopy; this was difficult to achieve as most of the patients had received intensive cytotoxic therapy and subsequently were severely myelosuppressive. Therefore, in achieving an adequate platelet count, the procedure was often delayed. A well-coordinated approach and aggressive platelet support should help in decreasing the time interval between onset of symptoms and BAL. Overall, the bronchoscopy procedure was well tolerated with minor reversible complications. We had a diagnostic yield of 65% similar as compared to the previously published study [Table 3].[14] However, the therapeutic utility or the change in the management was low as we usually start our therapy empirically. The identification of organisms ensured that the complete duration of antimicrobial therapy could be given to these patients as part of definitive therapy. Therefore, the actual benefit to the patients may have been higher than indicated. Furthermore, if these organisms are not eradicated fully, they could form part of resistant colonization. These could be the potential source of further morbidity in future chemotherapy.

Comparison of previous study evaluating pulmonary infiltrate in febrile neutropenic patients

Conclusion

Evaluation of pulmonary infiltrates in febrile neutropenia patients helps in optimizing antimicrobial therapy. Knowledge of prevalence of organisms and their sensitivity patterns would also help in formulating effective empiric antibiotic protocols. This would help in decreasing the morbidity and also in cutting the cost of antibiotic treatment. Our finding also emphasizes the importance of appropriate empirical antimicrobial therapy, which forms the mainstay of treatment for these patients. Our finding suggests that BAL has got several potential advantages in evaluating patients with hematological malignancies. However, it must be emphasized that the effectiveness of BAL depends on several local factors. The presence of good microbiological and cytopathological backup is crucial in analyzing the specimen. HRCT accurately correlates with the microbiological isolation. In summary, our experience with FOB and BAL in patients with hematological malignancies pulmonary infiltrates is encouraging. It has been a learning experience, and the results obtained would be of benefit in planning further studies.

Conflict of Interest

There are no conflicts of interest.

• References

•